NCT06772753View on ClinicalTrials.gov

Investigation of Psychedelic Effects in Psychoactive Substances

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 5, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Psychedelic Effects in Healthy Volunteers
Interventions
DRUG

Placebo

inactive substance

DRUG

Psilocybin

active comparator for psychedelic effects

DRUG

Ketamine

psychoactive substance

DRUG

Dextromethorphan (DXM)

psychoactive substance

DRUG

Dimethyltryptamine (DMT)

psychoactive substance

DRUG

Methylenedioxymethamphetamine (MDMA)

psychoactive substance

DRUG

Tetrahydrocannabinol (THC)

psychoactive substance

Trial Locations (1)

21218

RECRUITING

Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER